Related Experiment Videos
The South African bone marrow registry (SABMR) in 2004
Ernette D du Toit1, Veronica Borrill, Terry E-A Schlaphoff
1SABMR, Laboratory for Tissue Immunology, National Health Laboratory Service and University of Cape Town, Cape Town, South Africa.
Summary
The South African Bone Marrow Registry (SABMR) was founded to address rare HLA antigen needs in patients of African ancestry. SABMR now aims to increase genetic diversity by enrolling more Black and mixed-ancestry donors.
Area of Science:
- Hematology
- Immunogenetics
- Transplantation Medicine
Background:
- The South African Bone Marrow Registry (SABMR) was established in 1991 due to the critical need for rare Human Leukocyte Antigen (HLA) types, especially in patients of African ancestry.
- A significant portion of the international bone marrow registry's unique HLA types originate from SABMR, highlighting its global contribution.
Purpose of the Study:
- To address the underrepresentation of diverse HLA types within the SABMR donor pool.
- To enhance the probability of successful unrelated donor stem cell transplants for South African patients, particularly those of African ancestry.
Main Methods:
- The SABMR has amassed approximately 45,000 donors.
- Data indicates that 65 South African patients have received matched unrelated donor transplants, with 20% utilizing local donors.
- The registry's donor base is predominantly of Caucasian background.
Main Results:
- The SABMR currently holds about 20% of the unique HLA types in the international database.
- A substantial number of South African patients (65) have undergone matched unrelated donor transplants.
- A significant proportion (30%) of these transplants involved donors sourced locally within South Africa.
Conclusions:
- The SABMR plays a crucial role in providing rare HLA types for patients globally.
- There is a strategic imperative to increase the enrollment of Black and mixed-ancestry donors to improve genetic diversity.
- Expanding the donor pool's diversity is essential for improving transplant outcomes for all South African patients.